Dr. Reddy's Soars 1%: Can Earnings Beat Market Expectations?

Dr. Reddy’s Earnings Insight

[{"selector":"#anim-a2ea8a1f-f59e-417b-a337-85e20c170879","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-84c83e15-ec8d-48a2-93ca-7190ce47c896","keyframes":{"transform":["translate3d(122.53521%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Dr. Reddy’s to reveal its financial performance for December ’23 quarter today

[{"selector":"#anim-dc385c68-20b0-44cf-9b65-8689beea6cac","keyframes":{"opacity":[0,1]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-aef02f6b-af90-43f7-9eb0-93e8db2b74f7","keyframes":{"transform":["translate3d(-120.40817%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-94cae262-4198-4762-ae32-d79f52743094 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-0.2551020428065556%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Shares gain 1% in anticipation of strong earnings, following Cipla’s healthy December quarter.

[{"selector":"#anim-35252e42-d197-44f9-988d-f4141bf1ef0b [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(8.386009418119215%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-7a19b719-ad47-457e-8382-f2981b5a2c7f","keyframes":{"opacity":[0,1]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b613683a-a698-4daa-8219-0601e60a2f98","keyframes":{"transform":["translate3d(-116.56051%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Expected growth in the US, driven by significant product launches and reduced pricing pressure.

[{"selector":"#anim-97f53bef-33ec-42b5-9f35-946e62bc5b5b [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-4.104256942260122%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-73a77a1b-fc41-4fe2-bd61-f0582ce13327","keyframes":{"opacity":[0,1]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0ae510a3-8bd5-4111-a3d4-dc8d18554afd","keyframes":{"transform":["translate3d(-119.60785%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Despite a high base from last year’s Revlimid launch, Dr. Reddy’s US growth outlook remains positive.

[{"selector":"#anim-3bd4fe29-a092-4dca-a616-c14d99ddc946 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-2.5416037365729913%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-94cf5e62-7290-4c6c-acb4-34ab475515a9","keyframes":{"opacity":[0,1]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b38251bb-e59c-4ecc-9a23-9b4a9014c1ea","keyframes":{"transform":["translate3d(-119.60785%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Long-term growth remains intact with robust performance anticipated from US business and injectables.

[{"selector":"#anim-0d754e90-db1a-4a01-b4c9-e0708ac6966f [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(8.386009418119215%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-ea1693e3-8b73-4028-accb-3eb43b49b56e","keyframes":{"opacity":[0,1]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-89dad6da-f35c-4f18-82ed-7565194d2eb2","keyframes":{"transform":["translate3d(-119.60785%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Analysts to watch: China market penetration, US approvals, and launches driving earnings growth.

[{"selector":"#anim-53a0740d-ae5f-41df-b0dd-309527483150 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0.765306128419649%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-b0d3a8a3-35ae-4c36-998f-2e3fc5571f2f","keyframes":{"opacity":[0,1]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-498634e7-d49e-4f03-8794-afba2dd5c19c","keyframes":{"transform":["translate3d(-119.60785%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":650,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]